Skip to content

AutoContour Model RADAC V2

by Radformation, Inc. United States EUDAMED510(k)

510(k) K220598

Product code QKB

Overview

The AutoContour Model RADAC V2 is a radiological image processing software for radiation therapy, classified as a Class II device. It automates the segmentation of anatomical structures and organs at risk (OARs) using deep learning algorithms, generating planning-ready contours from CT, MR, or CBCT imaging data. This software streamlines the contouring process, reducing manual effort and improving consistency in treatment planning workflows.

Supplied as a standalone software solution, the AutoContour Model RADAC V2 is intended for use in radiation oncology departments by trained professionals. It operates on standard clinical imaging systems and does not require additional hardware. The device is cleared under the FDA’s 510(k) pathway as substantially equivalent to predicate devices, with regulatory compliance also meeting EU MDR requirements. No sterility or single-use specifications apply, as it is a reusable digital tool.

Summary written by AI from registry data, 18 Sep 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK220598 Date24 Aug 2022ClearedStatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Coverage

2 jurisdictions

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenSwedenLatviaEstoniaUnited States of AmericaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaFranceFranceAustriaHungaryRomaniaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaFranceFranceSloveniaBulgariaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaPortugalSpainSpainItalyUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSpainSpainCroatiaGreeceUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaMaltaCyprusUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Not covered
  • European Union CE/MDR Active
  • United States FDA 510(k) Active

Recalls: none on record (FDA, checked 22 Oct 2026)

Certificates: none listed in EUDAMED

Specification

EUDAMED · 510(k) · synced 22 Oct 2026

510(k) Number
FDA Product Code
QKB
Device Class
Class II
Regulation
21 CFR Part 892.2050
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Other devices from Radformation, Inc.

See all devices from Radformation, Inc. →

Questions

  • What types of imaging data can the AutoContour Model RADAC V2 process for radiation therapy planning?

    The AutoContour Model RADAC V2 is designed to work with CT, MR, and CBCT imaging data. It uses deep learning algorithms to automate the segmentation of anatomical structures and organs at risk, generating planning-ready contours from these modalities to streamline treatment planning workflows.

  • Is the AutoContour Model RADAC V2 a standalone software solution, or does it require additional hardware?

    The AutoContour Model RADAC V2 is supplied as a standalone software solution and does not require any additional hardware. It operates on standard clinical imaging systems already used in radiation oncology departments.

  • How does the AutoContour Model RADAC V2 improve the workflow for radiation therapy planning?

    The AutoContour Model RADAC V2 automates the segmentation of anatomical structures and organs at risk using deep learning, significantly reducing the manual effort required for contouring. This improves consistency in treatment planning workflows and helps trained professionals save time during radiation therapy planning.

  • What regulatory pathways has the AutoContour Model RADAC V2 followed for clearance?

    The AutoContour Model RADAC V2 has been cleared under the FDA’s 510(k) pathway as substantially equivalent to predicate devices. It also meets EU MDR (Medical Device Regulation) compliance requirements, ensuring it adheres to both U.S. and European regulatory standards.

  • Who is the intended user of the AutoContour Model RADAC V2, and where would it typically be used?

    The AutoContour Model RADAC V2 is intended for use in radiation oncology departments by trained professionals, such as radiation oncologists, medical physicists, or radiation therapists. It is specifically designed to assist in the contouring process for radiation therapy planning.

Properties & raw data

Show properties, registry sources and raw records

Sources (2)

  • FDA 510(k) K220598 24 fields · synced 22 Oct 2026
  • EUDAMED 1 fields · synced 3 Jun 2026